Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
31.2%  /
98.1%
0.3x
2.5x
0x
4.3%
0.0%
..
0.0%
--- 
43.1%  /
63.6%
>200x
>200x
3x
-3.5%
-11.9%
..
0.0%
-4.7% 
95.7%  /
48.6%
8.5x
18.5x
1.7x
20.0%
1.0%
2026-02-23
1.7%
0.8% 
146.7%  /
41.6%
40x
40.6x
2.7x
6.7%
-230.6%
..
0.0%
-2 148.1% 
>200%  /
40.0%
>200x
0x
0x
4.3%
0.0%
..
0.0%
91.0% 
-69.2%  /
34.2%
>200x
>200x
1.2x
-10.3%
-17.6%
2026-02-26
0.0%
-20.3% 
>200%  /
33.8%
13.7x
15.1x
0.3x
1.9%
3.4%
..
0.0%
46.4% 
6.6%  /
32.5%
8.6x
15.6x
1.1x
12.7%
11.3%
2026-02-24
0.0%
35.8% 
38.6%  /
31.8%
45.1x
71.2x
13.5x
30.0%
3.0%
..
0.4%
0.3% 
29.4%  /
30.6%
40.3x
72.8x
4.7x
11.6%
42.2%
2026-05-08
0.0%
9.3% 
42.5%  /
30.6%
7.5x
15.6x
2.3x
31.3%
-4.5%
..
3.7%
-3.4% 
>200%  /
30.5%
9.1x
13.6x
1.3x
14.2%
0.0%
..
4.1%
--- 
7.3%  /
27.8%
12x
39.4x
1x
8.0%
0.0%
2026-02-24
0.0%
--- 
17.6%  /
24.8%
3.7x
3.6x
0.4x
12.1%
10.1%
..
1.8%
25.7% 
-5.4%  /
24.3%
14.9x
17.9x
2.5x
17.0%
-2.8%
2026-05-03
8.3%
-3.5% 
-6.6%  /
24.2%
9.6x
17.1x
1.7x
17.4%
2.5%
..
1.1%
3.1% 
0.8%  /
22.8%
7x
9.5x
0.7x
10.2%
-2.4%
..
3.1%
-6.5% 
14.9%  /
20.6%
31.1x
40.5x
3.3x
10.7%
6.4%
2026-02-26
0.0%
2.2% 
23.5%  /
15.8%
18.8x
19.7x
2.4x
13.0%
0.0%
..
1.5%
--- 
5.1%  /
14.5%
12.4x
11.8x
3.1x
25.0%
13.9%
..
4.4%
4.8% 
1.0%  /
13.7%
16.3x
16.4x
2.6x
15.9%
11.0%
..
3.0%
5.1% 
4.9%  /
11.5%
24.5x
38.4x
4.9x
20.0%
-3.1%
2026-04-24
0.0%
-0.7% 
12.4%  /
9.6%
18.9x
17.8x
2x
10.4%
26.8%
..
0.0%
17.6% 
-6.2%  /
9.6%
13.5x
16.7x
1x
7.6%
1.8%
2026-02-26
5.1%
3.0% 
0.8%  /
9.3%
12.4x
12.4x
1.4x
11.3%
0.0%
..
0.0%
--- 
9.6%  /
8.7%
8.3x
13.9x
0.6x
7.6%
-37.4%
2026-02-25
0.0%
-57.5% 
6.2%  /
8.5%
8.8x
13.1x
0.7x
7.9%
-1.5%
2026-05-07
1.2%
-3.3% 
-1.8%  /
7.9%
13.7x
13.5x
1.7x
12.1%
-0.2%
..
0.0%
-0.3% 
8.8%  /
7.6%
9.1x
10.2x
1.6x
17.5%
7.1%
2026-05-01
2.1%
4.8% 
6.8%  /
7.5%
11.9x
15x
0.5x
4.4%
0.0%
2026-03-04
3.5%
--- 
-1.1%  /
6.3%
5.7x
4.9x
0.6x
10.0%
1.1%
..
0.0%
3.3% 
1.6%  /
6.0%
11.7x
11.8x
0.9x
7.5%
5.4%
..
0.0%
21.4% 
4.9%  /
5.3%
18.3x
18.1x
1.3x
6.9%
1.2%
2026-02-25
1.9%
1.7% 
5.5%  /
4.8%
29.2x
21x
3.6x
12.2%
3.0%
2026-04-30
2.5%
1.0% 
3.3%  /
4.3%
18.5x
15.5x
1.4x
7.4%
5.3%
..
0.0%
4.8% 
3.0%  /
4.2%
22x
20.5x
11.4x
52.6%
-4.3%
2026-03-08
2.1%
-0.5% 
6.9%  /
3.9%
21.1x
20.6x
7.5x
35.4%
16.5%
..
1.9%
2.8% 
1.7%  /
1.3%
5.4x
6.1x
0.6x
11.6%
1.7%
2026-03-12
0.0%
2.6% 
-5.6%  /
-1.5%
13.8x
55.4x
0.5x
4.4%
4.4%
2026-02-25
0.0%
75.4% 
-0.5%  /
-3.0%
3.8x
8.5x
2.5x
65.5%
-5.2%
2026-02-25
5.0%
-8.2% 
0.3%  /
-3.3%
2.3x
3x
0.1x
5.4%
-0.3%
2026-02-25
10.4%
-2.0% 
-3.9%  /
-3.4%
32x
32x
0.6x
2.0%
-0.4%
2026-03-05
0.0%
-5.9% 
-8.3%  /
-3.8%
10x
14.6x
0.4x
3.6%
5.8%
2026-05-09
0.0%
62.1% 
102.5%  /
-5.6%
>200x
19.5x
2.2x
-37.8%
34.4%
2026-02-23
3.6%
15.6% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2026-02-27
#reports #XRAY

[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195211)
(2026-02-26, After Market Close):

- Revenue +49.4% YoY (vs -4.9% in previous quarter and historical rate +9.5%)
- EBITDA margin -3.5% increased compared to -23.4% same period last year
- Net Debt decreased by $55 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.3% of market cap
- EV/Sales multiple is 0.8x

2026-02-27
#reports #XPOF

[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for 2025 q4
(2026-02-26, After Market Close):

- Revenue 0% YoY (vs -1.2% in previous quarter and historical rate +10.1%)
- EBITDA margin -7.2% increased compared to -56.6% same period last year
- Net Debt increased by $125 mln over the past reporting period (45.8% of market cap)
- FCF (LTM) +$1.6 bln (positive), 582.7% of market cap
- EV/EBITDA multiple is 34.1x compared to historical level (75th percentile) of 67.1x
- EV/Sales multiple is 3.5x

2026-02-27
#reports #WWW

[Wolverine World Wide](https://eninvs.com/all.php?name=WWW) (Clothing/shoes/accessories manufacturer) reported for 2025 q4
(2026-02-26, Before Market Open):

- Revenue +4.6% YoY (vs +6.8% in previous quarter and historical rate -10.1%)
- EBITDA +19.6% YoY (vs +9.1% in previous quarter and historical rate +25.8%)
- EBITDA margin 10.6% increased compared to 9.3% same period last year
- Net Debt decreased by $132 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) -$0 bln (negative), 2.3% of market cap
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 1.1x

2026-02-27
#reports #WRBY

[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for 2025 q4
(2026-02-26, Before Market Open):

- Revenue +11% YoY (vs +15.6% in previous quarter and historical rate +13.4%)
- EBITDA +71.4% YoY (vs +333.3% in previous quarter and historical rate +89.3%)
- EBITDA margin 5.7% increased compared to 3.7% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 94.9x compared to historical level (75th percentile) of 202.8x
- EV/Sales multiple is 3.8x

2026-02-27
#reports #VTRS

[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195208)
(2026-02-26, Before Market Open):

- Revenue +5% YoY (vs +0.2% in previous quarter and historical rate -4.1%)
- EBITDA -1% YoY (vs -20.9% in previous quarter and historical rate -20.6%)
- EBITDA margin 35.7% decreased compared to 37.9% same period last year
- Net Debt decreased by $372 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 177.2x compared to historical level (75th percentile) of 15.1x
- EV/Sales multiple is 2x

2026-02-27
#reports #VTEX

[VTEX](https://eninvs.com/all.php?name=VTEX) (Software — Application) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=6&id=230226)
(2026-02-26, After Market Close):

- Revenue +11.5% YoY (vs +9.8% in previous quarter and historical rate +22.0%)
- EBITDA margin 20.6% increased compared to -24.6% same period last year
- Net Debt decreased by $169 mln over the past reporting period (26.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 23.9x compared to historical level (75th percentile) of 186.4x
- EV/Sales multiple is 1.9x

2026-02-27
#reports #VCEL

[Vericel](https://eninvs.com/all.php?name=VCEL) (Medical services provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195207)
(2026-02-26, Before Market Open):

- Revenue +24% YoY (vs +17.2% in previous quarter and historical rate +18.7%)
- EBITDA +30% YoY (vs +500.0% in previous quarter)
- EBITDA margin 28.0% increased compared to 26.7% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 92.8x compared to historical level (75th percentile) of 724.3x
- EV/Sales multiple is 6.7x

2026-02-27
#reports #TTEC

[TTEC](https://eninvs.com/all.php?name=TTEC) (IT services provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195206)
(2026-02-26, After Market Close):

- Revenue +0.5% YoY (vs -1.9% in previous quarter and historical rate -4.2%)
- EBITDA -475% YoY (vs -7.9% in previous quarter and historical rate -26.3%)
- EBITDA margin -26.3% decreased compared to 7.1% same period last year
- Net Debt increased by $8 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 49.1% of market cap
- EV/Sales multiple is 0.5x

2026-02-27
#reports #TRS

[TriMas](https://eninvs.com/all.php?name=TRS) (Engergy services provider) reported for 2025 q4
(2026-02-26, Before Market Open):

- Revenue -32% YoY (vs +17.5% in previous quarter and historical rate +2.2%)
- EBITDA +85.2% YoY (vs +50.0% in previous quarter and historical rate +7.2%)
- EBITDA margin 32.3% increased compared to 11.8% same period last year
- Net Debt increased by $54 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2x

2026-02-27
#reports #TKNO

[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for 2025 q4
(2026-02-26, After Market Close):

- Revenue +11.1% YoY (vs 0.0% in previous quarter and historical rate -0.2%)
- EBITDA margin -50.0% increased compared to -66.7% same period last year
- EV/Sales multiple is 2.4x

2026-02-27
#reports #TFX

[Teleflex](https://eninvs.com/all.php?name=TFX) (Medical equipment manufacturer) reported for 2025 q4
(2026-02-26, Before Market Open):

- Revenue -28.4% YoY (vs +19.5% in previous quarter and historical rate +2.2%)
- EBITDA margin 4.9% increased compared to -11.1% same period last year
- Net Debt decreased by $80 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.7 bln (negative), 15.1% of market cap
- EV/Sales multiple is 2.3x

2026-02-27
#reports #STRA

[Strategic Education](https://eninvs.com/all.php?name=STRA) (Educational service provider) reported for 2025 q4
(2026-02-26, After Market Close):

- Revenue +3.9% YoY (vs +4.6% in previous quarter and historical rate +6.0%)
- EBITDA +89.4% YoY (vs +29.8% in previous quarter and historical rate +32.4%)
- EBITDA margin 27.6% increased compared to 15.1% same period last year
- Net Debt increased by $16 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 7.1x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 1.5x

2026-02-27
#reports #SNDX

[Syndax Pharmaceuticals](https://eninvs.com/all.php?name=SNDX) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195203)
(2026-02-26, After Market Close):

- Revenue +6700% YoY (vs +12600.0% in previous quarter and historical rate +50.0%)
- EBITDA margin -92.6% increased compared to -2700.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 25.6% of market cap
- EV/Sales multiple is 3.4x

2026-02-27
#reports #SMP

[Standard Motor Products](https://eninvs.com/all.php?name=SMP) (Auto parts manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195202)
(2026-02-26, Before Market Open):

- Revenue +342.6% YoY (vs +25.1% in previous quarter and historical rate +25.4%)
- EBITDA +661.5% YoY (vs +31.1% in previous quarter and historical rate +24.5%)
- EBITDA margin 6.5% increased compared to 3.8% same period last year
- Net Debt increased by $42 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 10.1x
- EV/Sales multiple is 0.5x

2026-02-27
#reports #SJM

[JM Smucker](https://eninvs.com/all.php?name=SJM) (Food manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195201)
(2026-02-26, Before Market Open):

- Revenue +7% YoY (vs +2.6% in previous quarter and historical rate +2.7%)
- EBITDA margin -17.3% increased compared to -21.6% same period last year
- Net Debt decreased by $449 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/Sales multiple is 2.1x

2026-02-27
#reports #SG

[Sweetgreen, Inc.](https://eninvs.com/all.php?name=SG) (Restaurants) reported for 2025 q4
(2026-02-26, After Market Close):

- Revenue -69.2% YoY (vs -6.3% in previous quarter and historical rate +34.2%)
- EBITDA margin -19.4% decreased compared to -4.6% same period last year
- Net Debt increased by $39 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.0% of market cap
- EV/Sales multiple is 1.2x

2026-02-27
#reports #RYTM

[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for 2025 q4
(2026-02-26, Before Market Open):

- Revenue +35.7% YoY (vs +54.5% in previous quarter and historical rate +106.6%)
- EBITDA margin -68.4% increased compared to -78.6% same period last year
- Net Debt decreased by $16 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/Sales multiple is 36.6x

2026-02-27
#reports #ROCK

[Gibraltar Industries](https://eninvs.com/all.php?name=ROCK) (Engineering materials and metals supplier) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195195)
(2026-02-26, Before Market Open):

- Revenue -80.6% YoY (vs -13.9% in previous quarter and historical rate +6.5%)
- EBITDA -86.3% YoY (vs -7.8% in previous quarter and historical rate +13.0%)
- EBITDA margin 7.8% decreased compared to 11.0% same period last year
- Net Debt decreased by $29 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.1% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 11.9x
- EV/Sales multiple is 1.2x

2026-02-27
#reports #REAL

[RealReal](https://eninvs.com/all.php?name=REAL) (Luxury Goods) reported for 2025 q4
(2026-02-26, After Market Close):

- Revenue +35.7% YoY (vs +11.3% in previous quarter and historical rate +12.4%)
- EBITDA margin 7.2% increased compared to -2.1% same period last year
- Net Debt increased by $31 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/Sales multiple is 3.6x

2026-02-27
#reports #PZZA

[Papa Johns International](https://eninvs.com/all.php?name=PZZA) (Owner of restaurants) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195193)
(2026-02-26, Before Market Open):

- Revenue -6.2% YoY (vs +0.2% in previous quarter and historical rate +9.6%)
- EBITDA +2.1% YoY (vs -72.3% in previous quarter and historical rate +20.4%)
- EBITDA margin 9.6% increased compared to 8.9% same period last year
- Net Debt decreased by $15 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 1x

2026-02-27
#reports #PUBM

[PubMatic, Inc.](https://eninvs.com/all.php?name=PUBM) (Software — Application) reported for 2025 q4
(2026-02-26, After Market Close):

- Revenue -7% YoY (vs -5.6% in previous quarter and historical rate +3.8%)
- EBITDA -13.3% YoY (vs -17.6% in previous quarter and historical rate +0.4%)
- EBITDA margin 65.0% decreased compared to 69.8% same period last year
- Net Debt decreased by $10 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 10.8x
- EV/Sales multiple is 0.9x